Revotar Biopharmaceuticals AG

Revotar Biopharmaceuticals AG

Revotar Biopharmaceuticals AG

Date Founded



Neuendorfstrasse 24 a,Hennigsdorf, Brandenburg 16761

Type of Company




Company Description

Revotar Biopharmaceuticals AG specializes in the research and development of anti-inflammatory drugs. The firm develops drugs for the therapy and treatment of inflammatory disorders such as psoriasis, asthma and acute lung injuries, and chronic obstructive pulmonary diseases. Its focus areas include product licensing, drug discovery, and clinical development. The firm also engages in partnerships and projects with biotechnology research institutions and pharmaceutical enterprises. The company was founded in August 2000 and is headquartered in Hennigsdorf, Germany.

Executives & Employees

Chief Executive Officer

Chief Financial Officer

Chief Scientific Officer

Supervisory Board

President & Chief Executive Officer, Diagnostics Division at Bayer HealthCare AG

Paths to Revotar Biopharmaceuticals AG
Potential Connections via
Relationship Science
Revotar Biopharmaceuticals AG
Details Hidden
Details Hidden

Encysive Pharmaceuticals, Inc. discovers, develops and markets drugs for the treatment of cardiovascular, vascular and related inflammatory diseases. The firm focuses its research and development programs on the treatment and prevention of interrelated diseases of the vascular endothelium, inflammatory cascade and vascular diseases. The company was founded by James T. Willerson in 1989 and is headquartered in Houston, TX.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Revotar Biopharmaceuticals AG. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Revotar Biopharmaceuticals AG's profile does not indicate a business or promotional relationship of any kind between RelSci and Revotar Biopharmaceuticals AG.
  • be_ixf; php_sdk; php_sdk_1.4.15